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According to a classical view of bacterial-host interactions at intestinal surfaces, the commensal microbiota
establishes tolerance, and invasive pathogens cause stereotypic inflammation. The reality is more complex,
marked by a ‘‘me´nage a` trois’’ situation encompassing three emerging concepts: (1) pathogens take advan-
tage of inflammation to cross the epithelial barrier, (2) pathogens reduce the commensal flora to invade their
niche, and (3) pathogens express dedicated effectors that modulate inflammation.Introduction
Intestinal inflammation occurs when an
enteric pathogen bypasses barriers
imposed by the commensal gut flora,
and the epithelial lining, or when innate
immune defects that largely remain to be
identified, disrupt tolerance to the resi-
dent microbiota. The later results in
inflammatory bowel diseases (IBDs),
Crohn’s disease being a typical example.
Here, we review and discuss the tumul-
tuous relationship entertained among
bacterial pathogens, commensals, and
inflammation, a ‘‘me´nage a` trois’’ that is
emerging as a new paradigm in patho-
genesis. Intestinal inflammation, the ste-
reotypical host innate response to a
bacterial pathogen, is expected to facili-
tate the pathogen’s eradication. In reality,
a much more subtle game is engaged in
which the pathogen subverts inflamma-
tion to escape its lethal effect, and con-
comitantly can take advantage of inflam-
mation to breach the barrier effect
imposed by the resident flora and the
epithelium itself. We will outline the dy-
namic mechanisms by which the resident
microbiota and the mucosa conjugate
efforts to maintain homeostasis, and
how it is disrupted by pathogens. We will
also consider how pathogens use the in-
flammation they elicit to subvert the inte-
grated barrier established by the resident
flora and the epithelium, and how they
eventually suppress this inflammation in
order to secure their colonization and full
invasion potential.344 Cell Host & Microbe 3, June 2008 ª200The Commensal, the Pathogen and
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Commensal bacteria that colonize the gut
protect the host from intruding pathogens
by imposing a colonization barrier, also
called the barrier effect (Stecher and
Hardt, 2008). This protective community
composed of 500–1000 species of micro-
organisms reaching a concentration of
1011 bacteria per gram of colon content
cannot be ignored by the host. Commen-
sals as well as pathogens are character-
ized by the presence of molecular pat-
terns (PAMPs) that are specific to the
prokaryotic world. As a complement, the
epithelial lining and associated cells ex-
press an array of pathogen-recognizing
receptors (PRRs) that, upon activation
by the PAMPs, should induce inflamma-
tion (for details, see the Review by Ishii
et al., page 352 in this issue). Clearly
this is not always the case, as chronic
inflammation is detrimental to the host.
Thus, host defenses are able to accu-
rately interpret the microbial environment
in order to discriminate between perma-
nently established commensal microbes
and episodic pathogens.
One can envision four major sets of
parameters supporting the largely active
tolerogenic process that maintains ho-
meostasis. (1) Bacteria may escape or al-
ter the inflammatory response. They may
remain ‘‘stealth,’’ due to yet-to-be ex-
plored diversity in PAMPs, such as penta-
cylated lipidA of anaerobic gram-negative
commensals (i.e., Bacteroidetes) that are8 Elsevier Inc.unable to signal via TLR4, the poor
agonist activity of flagellin for TLR5, or
variability in peptidoglycan. Commensal
bacteria may also actively suppress
epithelial proinflammatory signaling, as
demonstrated for Bacteroides thetaiotao-
micron that induce export of RelA, the p65
subunit of the proinflammatory transcrip-
tion factor NF-kB, out of the nucleus lead-
ing to decreased transcription of NF-kB-
dependent genes (Kelly et al., 2004), and
for Lactobacillus casei that suppress deg-
radation of the inhibitor of NF-kB, I-kB
(Tien et al., 2006). (2) The host may ex-
press factors and enzymes that assist in
tolerating the commensal by blunting mi-
crobial components that would typically
induce inflammation. For example, recent
evidence indicates that the brush border
alkaline phosphatase expressed in the
intestinal epithelium can detoxify luminal
LPS by dephosphorylating the lipid A
(Bates et al., 2007). (3) There is also
a physical dimension to the tolerogenic
process. This includes the combined pro-
duction of mucus and antibacterial mole-
cules, particularly antimicrobial peptides
(AMP), by the epithelial lining (Lie´vin-Le
Moal and Servin, 2006). The mucus
serves as a matrix for the AMPs secreted
by epithelial cells, and together they are
likely to maintain commensals restrained
and separated from the epithelial surface.
Consistent with this hypothesis of a ‘‘no-
bacteria zone’’ created over a certain
distance from the epithelial surface is
the observation that in Crohn’s disease,
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expression of AMPs by the intestinal and
colonic epithelium (Nuding et al., 2007),
bacteria gain close access to the epithe-
lial surface on which they grow as a thick
layer (Swidsinski et al., 2002). Further, in
such a situation the diversity of the micro-
biota gets reduced (Manichanh et al.,
2006), indicating a strong impact of
chronic inflammation on the composition
of the resident flora. (4) The third compo-
nent is a more immunological one. A sig-
nificant sequestration of PRRs seems to
exist with little presence of TLR4 and/or
coactivation molecules (i.e., MD2 and
CD14) in the gut surface epithelium, thus
a certain degree of ‘‘blindness’’ of the sur-
face most exposed to the resident flora
(Abreu et al., 2005). Also, the epithelial
lining gets tolerized to LPS very early in
life (Lotz et al., 2006), and the integrated
mucosal immune system is strongly ori-
ented to tolerance, with epithelial signals
such as the production of Thymic stromal
lymphopoietin orienting T cell responses
toward noninflammatory (i.e., non Th1)
responses (Rimoldi et al., 2005). T regula-
tory lymphocytes (Treg) producing IL-10
and TGF-b are essential final effectors of
tolerance to the resident flora (Izcue
et al., 2006). Last but not least, the adap-
tive immune system is enrolled in the
tolerogenic process through the local
production of commensal-specific IgA(s)
that seem, experimentally, to be able to re-
duce intestinal proinflammatory signaling
(Peterson et al., 2007; also see Review by
Peterson et al., page 417 in this issue).
It is clear that pathogens have the ca-
pacity to subvert the four levels of security
defined above by managing close access
to the epithelial surface, then defying the
mucosal innate immune network of micro-
bial sensing by delivering PAMPs in close
proximity to epithelial sensors, and ulti-
mately by invading the tissue. Altogether,
these signals incite a rapid inflammatory
host response characterized by secretion
of proinflammatory cytokines and chemo-
kines attracting neutrophils, monoytes,
and DCs to the site of infection aimed at
bacterial eradication. This phase corre-
sponds to the first level of complexity in
the me´nage a trois.
Diversion of Inflammation
by Pathogens
Pathogens exploit host inflammation to
colonize and/or invade their host. Al-though this may seem like an emerging
theme, it was shown more than 40 years
ago that Listeria monocytogenes invades
recruited monocytes and uses them as
vehicles to spread to distant tissues
(Gray and Killinger, 1966). In the case of
Shigella infection, blocking the recruit-
ment and epithelial transmigration of
neutrophils by systemic administration of
an anti-CD18 monoclonal antibody pre-
vented the rupture of the epithelial bar-
rier’s coherence and thereby blocked
both inflammation and bacterial invasion
of the epithelial lining (Perdomo et al.,
1994). This experiment illustrated the
capacity of an inflammatory infiltrate to
facilitate the passage of a host barrier.
From the perspective of the pathogen,
this access was gained at the cost of bac-
terial killing and thus at the risk of abortive
infection. However, the central question is
whether this somewhat provocative con-
cept can be generalized to other chronic
and acute infection systems and whether
inflammation, through rupture of the
epithelial barrier, is a primary contributor
to bacterial infection.
It has been shown that proinflammatory
cytokines, such as IFN-g and TNF-a, can
disrupt the epithelial barrier by inducing
increased paracellular permeability via
tight junctions disruption (Bruewer et al.,
2003). Moreover, gastric epithelial inflam-
mation seems to be vital for Helicobacter
pylori to establish long-term colonization
(Mimuro et al., 2007). Inflammation can
also be a secondary contributor by elimi-
nating a significant part of the resident
flora, thereby altering its colonization bar-
rier effect. Studies indicating that antibi-
otic treatment facilitates gut invasion by
enteric bacteria support the idea that
changes in the intestinal flora allow infec-
tion by pathogens (Beaugerie and Petit,
2004). Emerging evidence suggests that
pathogens can themselves alter the resi-
dent flora, a grand classic in me´nage a`
trois, where the lover kills the husband
with his mistress’ complicity. This was
recently described in a mouse model of
gut infection by Citrobacter rodentium
and Campylobacter jejuni, which are
murine enteric pathogens similar to entero-
pathogenic E. coli. Comparing with chem-
ically and genetically induced models of
gut mucosal inflammation, the authors
showed that as bacterial infection pro-
ceeds, the resident colonic microflora
undergo reduction and simplification,Cell Host & Mwhereas the potentially pathogenic aero-
bic bacteria, particularly Enterobacteria-
ceae, flourishes. These drastic changes
of the resident flora clearly correlated
with facilitation of C. rodentium infection
(Lupp et al., 2007). Although the mecha-
nisms promoting these changes remain
unclear, one can hypothesize that bacteri-
cidal mediators produced by the inflamed
epithelium in response to bacterial infec-
tion (e.g., reactive oxygen radicals, NO,
AMPs) result in microbial selection based
on the relative intrinsic resistance of the
resident and invading species to these
effectors. This is somewhat similar to the
situation with Crohn’s disease, during
the course of which a subpopulation of
resistant species that can live in close
contact with the epithelial surface is se-
lected (Conte et al., 2006). The selected
bacterial species include Enterobacteria-
cea, and possibly particularly resistant
bacteria such as the new class of adher-
ent-invasive E.coli (Barnich et al., 2007)
that are currently considered hypothetical
disease-causative agents. Mice infected
with Salmonella Enterica serovar Typhi-
murium also exhibited reduction and sim-
plification of the resident microflora, for
example a decrease in Lactobacillus and
Bacteroides spp., these changes being
correlated with expression of S. Enterica
virulence factors (Stecher et al., 2007;
Barman et al., 2008). It has been sug-
gested that the inflammatory mucosa
represents a source of nutrients that
Salmonella use for their growth (Stecher
and Hardt, 2008). From a Darwinian per-
spective, mucosal inflammation that has
been ‘‘mastered’’ by pathogens may pro-
vide these bacteria with variety of options,
such as solving particular metabolic
needs, eliminating the colonization barrier
of the commensal flora, and disrupting the
physical barrier of the epithelium. Such
a hypothesis holds true only if pathogens
can actually ‘‘master’’ inflammation;
otherwise, they are likely to incinerate in
the fire they lit.
Subversion of Inflammation
by Pathogens
Among their capacities to manipulate
a broad array of pathways in their target
cells, enteropathogenic bacteria have de-
veloped sophisticated strategies to mas-
ter inflammation (Bhavsar et al., 2007).
They alter inflammation qualitatively and
quantitatively in a way compatible withicrobe 3, June 2008 ª2008 Elsevier Inc. 345
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growth capacities, to enhance coloniza-
tion potential and, if required, invasion.
Bacterial effectors are now recognized
to directly modulate proinflammatory
pathways in order to limit detrimental in-
flammation, although in vivo confirmation
is still often warranted. A Shigella effector,
OspG, inhibits the NF-kB pathway. It is
a kinase that binds a subset of ubiquitin-
conjugating enzymes (E2s), thereby pre-
venting ubiquitination of phosphorylated
I-kB, which is consequently not degraded
by the proteasome, making OspG a potent
anti-inflammatory effector in an in vivo
model of infection (Kim et al., 2005). Yet
another Shigella effector, OspF, is a phos-
phothreonine-lyase that dephosphory-
lates two MAPKs (p38 MAPK and ERK2)
in the nucleus, blocking the phosphory-
lation of histone H3 on Ser10, and con-
sequently inhibiting activation of genes
under NF-kB control. This mechanism
translates in vivo to the regulation of re-
cruitment and transmigration of neutro-
phils to the site of infection (Arbibe et al.,
2007). Epigenetic regulation of inflamma-
tory responses by pathogens may turn
out to represent a major strategy able to
regulate restricted sets of proinflamma-
tory cytokines, and possibly imprint this
regulation for long periods in the course
of the infectious process. Haller and col-
leagues showed that TGF-b1 expression
induced by Bacteroides vulgatus inhibits
NF-kB activation through histone acetyla-
tion (Haller et al., 2003). Listeriolysin O,
a membranolytic toxin secreted by L.
monocytogenes, was shown to modulate
host gene expression by inducing de-
phosphorylation of Ser10 on histone H3,
and deacetylation of histone H4, leading
to decreased expression of proinflamma-
tory chemokines like CXCL2 (Hamon
et al., 2007). In addition to OspF regulating
neutrophil infiltration, Osp and IpaH effec-
tors, a novel family of E3 ligases (Rohde
et al., 2007), were recently shown to col-
lectively suppress expression of AMPs,
particularly human b-defensin-3 (HBD3)
and cathelicidin LL-37, that are bacteri-
cidal to Shigella (Spe´randio et al., 2008).
‘‘Spilling oil on the fire’’ cannot be a sus-
tainable strategy for a pathogen, which
will eventually perish in this risky strategy.
It is thus not surprising that, under such
strong selective pressure, enteropatho-
gens have accumulated a collection of
dedicated regulators of the host innate346 Cell Host & Microbe 3, June 2008 ª200response. Compromising is a general
rule, even in me´nages a` trois.
Conclusion
Future studies will make increasing sense
of the molecular strategies used by path-
ogens to ‘‘carve’’ a host innate response
that is compatible with their survival and
proliferation. It is already clear that in
niches that harbor a permanently resident
flora, pathogenesis cannot be considered
under the simplistic angle of a dual
host-pathogen interaction. It is a me´nage
a` trois, a three-partners’ story that prom-
ises much more exciting scenarios.
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